CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleMarket cap is $1.92B, above the global median of $1.15B
- PositionP/E ratio is 15.89×, lower than 95% of its Diagnostics & Research peers (median 46.94×)
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
4.31%Below 5Y avg (5.33%)
Annual Rate
BRL 0.80Paid semi-annual
Payout Ratio
104.2%High
Payback Period
14.0 yr
Last Ex-Dividend
Aug 12, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.86BBRL1.92B · vs all stocks (USD)
Trailing P/E
15.89xvs Diagnostics & Research peers
Revenue (TTM)
8.79BBRL1.71B · vs all stocks (USD)
Profit Margin
8.01%vs Diagnostics & Research peers
52-Week Change
30.89%vs all stocks
Forward Annual Dividend Yield
4.31%vs all stocks
Market Capitalization
9.86BBRL1.92B · vs all stocks (USD)
Enterprise Value
13.45BBRL2.61B · vs all stocks (USD)
Trailing P/E
15.89xvs Diagnostics & Research peers
Forward P/E
12.23xvs Diagnostics & Research peers
PEG Ratio
1.31xvs Diagnostics & Research peers
Price to Sales (TTM)
1.14xvs Diagnostics & Research peers
Price to Book (MRQ)
2.01xvs Diagnostics & Research peers
Enterprise to Revenue
1.53xvs Diagnostics & Research peers
Enterprise to EBITDA
6.81xvs Diagnostics & Research peers
Gross Margin
28.25%vs Diagnostics & Research peers
Profit Margin
8.01%vs Diagnostics & Research peers
Operating Margin
17.14%vs Diagnostics & Research peers
Return on Assets (TTM)
6.47%vs Diagnostics & Research peers
Return on Equity (TTM)
12.62%vs Diagnostics & Research peers
Revenue (TTM)
8.79BBRL1.71B · vs all stocks (USD)
Revenue per Share (TTM)
15.21BRLUpdated Aug 21, 2026Quarterly Revenue Growth
14.40%vs Diagnostics & Research peers
Gross Profit (TTM)
2.38BBRL462.38M · vs all stocks (USD)
EBITDA (TTM)
2.45BBRL476.92M · vs all stocks (USD)
Net Income (TTM)
704.31MBRL136.94M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
45.70%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
2.28BBRL444.24M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
840.42MBRL163.40M · vs all stocks (USD)
Forward Annual Dividend Rate
0.8015BRLUpdated Aug 21, 2026Forward Annual Dividend Yield
4.31%vs all stocks
Trailing Annual Dividend Rate
1.30BRLUpdated Aug 21, 2026Trailing Annual Dividend Yield
6.99%vs all stocks
5-Year Average Dividend Yield
5.33%vs all stocks
Payout Ratio
104.24%vs Diagnostics & Research peers
Minority Interest (Equity)
94.93MBRLFY2025 · Dec 31, 2025Revenue
8.29BBRLFY2025 · Dec 31, 2025Cost of Goods Sold
6.09BBRLFY2025 · Dec 31, 2025Gross Profit
2.21BBRLFY2025 · Dec 31, 2025Operating Income
1.24BBRL241.27M · vs all stocks (USD)
Pre-tax Income
753.21MBRLFY2025 · Dec 31, 2025Income Tax Expense
156.54MBRLFY2025 · Dec 31, 2025Net Income
596.67MBRLFY2025 · Dec 31, 2025EBIT
1.48BBRLFY2025 · Dec 31, 2025EBITDA (Income Statement)
2.40BBRLFY2025 · Dec 31, 2025Selling, General & Administrative
244.59MBRLFY2025 · Dec 31, 2025Other Operating Expenses
30.74MBRLFY2025 · Dec 31, 2025Non-operating Interest Income
346.80MBRLFY2025 · Dec 31, 2025Non-operating Interest Expense
723.73MBRLFY2025 · Dec 31, 2025Net Income from Continuing Operations
596.67MBRLFY2025 · Dec 31, 2025Minority Interests (P&L)
16.16MBRLFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00BRLFY2025 · Dec 31, 2025Operating Cash Flow
794.26MBRLFY2025 · Dec 31, 2025Free Cash Flow
288.19MBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
21.77MBRLFY2025 · Dec 31, 2025Starting Profit (CF Statement)
596.67MBRLFY2025 · Dec 31, 2025Stock-based Compensation
29.05MBRLFY2025 · Dec 31, 2025Other Non-cash Items
531.97MBRLFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-255.99MBRLFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-107.44MBRLFY2025 · Dec 31, 2025Capital Expenditures
-506.07MBRLFY2025 · Dec 31, 2025Net Acquisitions
-180.99MBRLFY2025 · Dec 31, 2025Net Investing Cash Flow
-687.06MBRLFY2025 · Dec 31, 2025Long-term Debt Issuance
116.13MBRLFY2025 · Dec 31, 2025Long-term Debt Payments
-221.95MBRLFY2025 · Dec 31, 2025Common Stock Repurchase
0.00BRLFY2025 · Dec 31, 2025Common Dividends Paid
-513.05MBRLFY2025 · Dec 31, 2025Other Financing Charges
-3.71MBRLFY2025 · Dec 31, 2025Net Financing Cash Flow
-622.60MBRLFY2025 · Dec 31, 2025Shares Outstanding
543.63MSharesUpdated Aug 21, 2026Float Shares
241.71MSharesUpdated Aug 21, 2026% Held by Insiders
55.37%vs all stocks
% Held by Institutions
25.01%vs all stocks
Total Cash (MRQ)
1.90BBRL369.25M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.48BRLUpdated Aug 21, 2026Total Debt (MRQ)
5.41BBRL1.05B · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.9802xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.86xvs Diagnostics & Research peers
Book Value per Share (MRQ)
9.18BRLUpdated Aug 21, 2026Total Assets
13.22BBRL2.57B · vs all stocks (USD)
Total Current Assets
4.42BBRLFY2025 · Dec 31, 2025Total Liabilities
8.12BBRLFY2025 · Dec 31, 2025Total Non-current Assets
8.80BBRLFY2025 · Dec 31, 2025Total Non-current Liabilities
5.88BBRLFY2025 · Dec 31, 2025Total Current Liabilities
2.25BBRLFY2025 · Dec 31, 2025Cash & Cash Equivalents
21.77MBRLFY2025 · Dec 31, 2025Other Short-term Investments
2.14BBRLFY2025 · Dec 31, 2025Accounts Receivable
1.75BBRLFY2025 · Dec 31, 2025Inventory
180.70MBRLFY2025 · Dec 31, 2025Accounts Payable
800.13MBRLFY2025 · Dec 31, 2025Short-term Debt
550.84MBRLFY2025 · Dec 31, 2025Other Current Liabilities
2.17MBRLFY2025 · Dec 31, 2025Long-term Debt
4.72BBRLFY2025 · Dec 31, 2025Other Non-current Liabilities
71.00MBRLFY2025 · Dec 31, 2025Common Stock (Book)
2.74BBRLFY2025 · Dec 31, 2025Retained Earnings
332.45MBRLFY2025 · Dec 31, 2025Total Shareholders' Equity
5.10BBRL990.87M · vs all stocks (USD)
Treasury Stock
35.56MBRLFY2025 · Dec 31, 202552-Week Low
13.84BRLUpdated Aug 21, 202652-Week High
19.73BRLUpdated Aug 21, 202652-Week Change
30.89%vs all stocks
50-Day MA
16.37BRLUpdated Aug 21, 2026200-Day MA
16.03BRLUpdated Aug 21, 2026Avg 10-Day Volume
5.29MSharesUpdated Aug 21, 2026Avg 30-Day Volume
3.12MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
1.16BRLUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 15.89×, lower than 95% of its Diagnostics & Research peers (median 46.94×)Notable
P/E ratio: 15.89Industry median: 46.94Industry P5: 19.63Peers compared: 28.00
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.04Dividend per Share: 1.30Earnings per Share: 1.16
Financial Health
Altman Z-Score 1.89: grey zoneSignificant
Altman Z-Score: 1.89
High earnings qualityNotable
Earnings Quality Score: 1.01
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Market cap is $1.92B, above the global median of $1.15BNotable
Market cap (USD): 1,916,291,026.849Global Median: 1,146,734,693.424
Revenue is $1.71B, above the global median of $520.53MNotable
Revenue (USD): 1,709,301,835.192Global Median: 520,528,949.311
Levered free cash flow is $163.4M, above the global median of $16.24MNotable
Levered free cash flow (USD): 163,402,107.767Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Wintech-Nano Suzhou Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Xi'an Novastar Tech Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Azad Engineering Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Shenzhen Dynanonic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Interface Inc.
Tier 1ProductionThroughput-Bound ConversionAttentionRule
Shenzhen KTC Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
ElvalHalcor S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ningbo Yunsheng (Group) Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Xi'an Sinofuse Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Hexing Electrical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Coforge Limited
3 interpretationsRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income Growth
Minda Corporation Ltd.
3 interpretationsRevenue Growing With Receivables GrowingOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income Growth
JCHX Mining Management Co., Ltd.
2 interpretationsOperating Income Growing With Multi-Year Revenue GrowthMulti-Year Revenue, Profit, And Income Growth